Clinical trial
Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLC
NCT02824952
Study timeline
Study start (actual)2018-11-01Date precision: day
Registry last updated2021-11-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancer, Non-small Cellunresolved
Interventions
TagrissoDRUG · verified · RxNorm: Tagrisso
Sponsors & collaborators
Shaare Zedek Medical Centerlead sponsor
AstraZenecacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02824952 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.